Company profile: PreventionGenetics
1.1 - Company Overview
Company description
- Provider of comprehensive genetic testing services, including whole-genome (PGnome) and whole-exome (PGxome) sequencing; targeted panels across endocrinology, hematology, and immunology; and Sanger sequencing, aCGH, and MLPA to detect and confirm genetic variants, deletions, and duplications across nearly all clinically relevant genes.
Products and services
- PGxome: A powerful whole-exome sequencing test that focuses on coding regions to detect genetic mutations with exome-level specificity
- PGnome: A comprehensive whole-genome sequencing test that analyzes the entire genome to identify genetic variants
- Genetic Testing Panels: Targeted panels that address specific genetic disorders across endocrinology, hematology, and immunology, enabling focused analysis of clinically relevant genes.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to PreventionGenetics
Quantgene
HQ: United States
Website
- Description: Provider of genomics and AI solutions in cancer diagnostics and liquid biopsy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Quantgene company profile →
SoftGenetics
HQ: United States
Website
- Description: Provider of genetic analysis software for researchers and clinicians, including Mutation Surveyor for Sanger DNA variant detection with custom reporting and user management; NextGENe for NGS SNP/indel, structural variant and transcriptome analysis; Geneticist Assistant for NGS variant interpretation, tracking and coverage confirmation; GeneMarker/HTS/MTP for genotyping, forensic NGS and multiple template processing, compatible with major sequencing systems.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SoftGenetics company profile →
SeQure Dx
HQ: United States
Website
- Description: Provider of safety data and diagnostic platforms for on- and off-target CRISPR gene editing therapies. Offers NoteSeQ (ONE-seq) for profiling off-target sites, ScopeSeQ for validating candidate edits via next-generation sequencing, risk assessment across the development lifecycle, discovery/IND support, clinical trial patient risk management, and post-approval diagnostic management with patient and physician education.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SeQure Dx company profile →
Ultima Genomics
HQ: United States
Website
- Description: Provider of a low-cost sequencing platform and related workflows, including the UG 100™ high-throughput system using a 200mm open silicon wafer with built-in automation; ppmSeq™ for rare event detection at one part per million for liquid biopsies and MRD; large-scale single-cell and spatial sequencing workflows; RNA-Seq for gene expression and isoform analysis; and genome-wide methylation sequencing compatible with standard tools.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ultima Genomics company profile →
Microsynbiotix
HQ: Ireland
Website
- Description: Provider of technology to eliminate excessive antibiotic use in farmed fish by engineering microalgae, leveraging advances in algal genomics and molecular biology to express inexpensive therapeutic proteins and vaccines of economic value.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Microsynbiotix company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for PreventionGenetics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to PreventionGenetics
2.2 - Growth funds investing in similar companies to PreventionGenetics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for PreventionGenetics
4.2 - Public trading comparable groups for PreventionGenetics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →